Reperfusion therapy for ST elevation myocardial infarction in low- to middle-income countries: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent – Save a Life! Initiative
Recommendations
As issued by the authors
Flexible three-model pathway for ST-elevation myocardial infarction (STEMI) care: fibrinolysis model, pharmaco-invasive strategy model and primary percutaneous coronary intervention (PCI) model, tailored to local circumstances
Addresses delayed access to primary PCI, reperfusion in cardiogenic shock with expected delayed PCI, fibrinolysis at high bleeding risk, and absence of fibrin-specific fibrinolytics, catheterization labs or any reperfusion therapy
Continuous improvement, patient education and secondary prevention strategies
Original publication
Reperfusion therapy for ST elevation myocardial infarction in low- to middle-income countries: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent – Save a Life! Initiative. Eur Heart J Acute Cardiovasc Care. Published 9 September 2025. doi:10.
Summarised from the published abstract; every number is checked against it